Skip to main content
Equibles

Allianz Asset Management GmbH

Position in ALKS — Alkermes plc.

CIK 1535323 MUNICH, 2M
Back to ALKS Full portfolio

Position in ALKS

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$4,805,499
+$1,963,970 QoQ
Shares Held
91,708
+14.1% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#126
of 423 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $169,714,679 across 14 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 710,401 $51,049,414
2 VTRS
Viatris Inc
 2,485,117 $39,463,657
3 UTHR
UNITED THERAPEUTICS Corp
 46,376 $25,127,906
4 TEVA
Teva Pharmaceutical Industries Ltd
 572,718 $19,403,685
5 ELAN
Elanco Animal Health Inc
 296,510 $7,297,110
6 HCM
HUTCHMED (China) Ltd
 674,511 $7,257,737
7 HIMS
Hims & Hers Health, Inc.
 166,476 $5,771,722
8 ALKS
Alkermes plc.
This page 		91,708 $4,805,499

All Filings in ALKS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,805,499 91,708
2026-03-31 $2,841,529 80,360
2025-12-31 $9,717,677 347,308
2025-09-30 $15,743,850 524,795
2025-06-30 $374,590 13,093
2025-03-31 $808,990 24,500
2024-12-31 $928,948 32,300
2024-09-30 $904,077 32,300
2024-06-30 $1,010,922 41,947
2024-03-31 $596,812 22,047